Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia.

Malaria Journal
Emiliana TjitraTrihono

Abstract

A practical and simple regimen for all malaria species is needed towards malaria elimination in Indonesia. It is worth to compare the efficacy and safety of a single dose of artemisinin-naphthoquine (AN) with a three-day regimen of dihydroartemisinin-piperaquine (DHP), the existing programme drug, in adults with uncomplicated symptomatic malaria. This is a phase III, randomized, open label using sealed envelopes, multi-centre, comparative study between a single dose of AN and a three-day dose of DHP in Jayapura and Maumere. The modified WHO inclusion and exclusion criteria for efficacy study were used in this trial. A total of 401 eligible adult malaria subjects were hospitalized for three days and randomly treated with AN four tablets single dose on day 0 or DHP three to four tablets single daily dose for three days, and followed for 42 days for physical examination, thick and thin smears microscopy, and other necessary tests. The efficacy of drug was assessed by polymerase chain reaction (PCR) uncorrected and corrected. There were 153 Plasmodium falciparum, 158 Plasmodium vivax and 90 P. falciparum/P. vivax malaria. Mean of fever clearance times were similar, 13.0 ± 10.3 hours in AN and 11.3 ± 7.3 hours in DHP groups. The mea...Continue Reading

References

Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mey Bouth DenisDoung Socheat
Jan 28, 2004·Acta Tropica·Jing-yan WangBo-an Wu
Mar 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A R HasugianR N Price
Sep 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maciej F BoniRamanan Laxminarayan
Jun 16, 2010·BMJ : British Medical Journal·Iosief Abraha, Alessandro Montedori

❮ Previous
Next ❯

Citations

Dec 21, 2012·Antimicrobial Agents and Chemotherapy·Inge SutantoJ Kevin Baird
Oct 8, 2013·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·L PullJ Y Siriez
Aug 12, 2014·Expert Opinion on Pharmacotherapy·Benjamin J VisserMartin P Grobusch
Apr 15, 2016·Drugs·Brioni R MooreTimothy M E Davis
Feb 24, 2015·The Cochrane Database of Systematic Reviews·Rachel IsbaDavid Sinclair
Jan 21, 2014·The Cochrane Database of Systematic Reviews·Babalwa ZaniDavid Sinclair
Oct 29, 2013·The Cochrane Database of Systematic Reviews·Nithya GogtayDavid Sinclair
Jan 6, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Stephanie D KovacsAndy Stergachis
Nov 30, 2019·Future Medicinal Chemistry·Ishan WadiAbhinav Sinha
Jan 23, 2019·Transactions of the Royal Society of Tropical Medicine and Hygiene·Samar N El-BeshbishiAmira Taman
Apr 17, 2013·Bioorganic & Medicinal Chemistry Letters·Marco A BiamonteKarine G Le Roch
Jul 21, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Henglin YangLiwang Cui

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping

Software Mentioned

EpiData
SPSS

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.